These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 79630)

  • 21. Steroid receptor content in cytosol from normal and hyperplastic human prostates.
    Ekman P; Snochowski M; Dahlberg E; Bression D; Högberg B; Gustafsson JA
    J Clin Endocrinol Metab; 1979 Aug; 49(2):205-15. PubMed ID: 88456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial characterisation of oestrogen receptors in canine mammary tumour lines maintained in nude mice.
    Thomas SE; Thomas N; Pierrepoint CG
    Eur J Cancer Clin Oncol; 1983 Jul; 19(7):989-94. PubMed ID: 6684054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitation of cytosolic and nuclear estrogen and progesterone receptor in benign, untreated, and treated malignant human prostatic tissue by radioligand binding and enzyme-immunoassays.
    Mobbs BG; Johnson IE; Liu Y
    Prostate; 1990; 16(3):235-44. PubMed ID: 1691841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen receptors in the human prostate, seminal vesicle, epididymis, testis, and genital skin: a marker for estrogen-responsive tissues?
    Murphy JB; Emmott RC; Hicks LL; Walsh PC
    J Clin Endocrinol Metab; 1980 May; 50(5):938-48. PubMed ID: 7372780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased prostatic secretory function in canine benign prostatic hyperplasia is not due to decreased levels of muscarinic cholinergic receptors.
    Lepor H; Berry SJ
    J Urol; 1984 Apr; 131(4):803-5. PubMed ID: 6200613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of estrogen and androgen receptor levels in human prostatic tissue from patients with non-metastatic and metastatic carcinoma and benign prostatic hyperplasia.
    Kirdani RY; Emrich LJ; Pontes EJ; Priore RL; Murphy GP
    J Steroid Biochem; 1985 May; 22(5):569-75. PubMed ID: 2409353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgen and oestrogen binding in cytosols of human ovarian tumours.
    Hamilton TC; Davies P; Griffiths K
    J Endocrinol; 1981 Sep; 90(3):421-31. PubMed ID: 7276800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assay of nuclear androgen receptor in human prostate.
    Lieskovsky G; Bruchovsky N
    J Urol; 1979 Jan; 121(1):54-8. PubMed ID: 83397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen receptor in human benign prostatic hyperplasia.
    Donnelly BJ; Lakey WH; McBlain WA
    J Urol; 1983 Jul; 130(1):183-7. PubMed ID: 6191047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carcinogen-binding proteins in the rat ventral prostate: specific and nonspecific high-affinity binding sites for benzo(a)pyrene, 3-methylcholanthrene, and 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Söderkvist P; Poellinger L; Gustafsson JA
    Cancer Res; 1986 Feb; 46(2):651-7. PubMed ID: 3940634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of androgen, oestrogen alpha and beta, and progesterone receptors in the canine prostate: differences between normal, inflamed, hyperplastic and neoplastic glands.
    Gallardo F; Mogas T; Baró T; Rabanal R; Morote J; Abal M; Reventós J; Lloreta J
    J Comp Pathol; 2007 Jan; 136(1):1-8. PubMed ID: 17078963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization and localization of the muscarinic cholinergic receptor in human prostatic tissue.
    Lepor H; Kuhar MJ
    J Urol; 1984 Aug; 132(2):397-402. PubMed ID: 6204069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A specific 17beta-estradiol receptor in human benign hypertrophic prostrate.
    Bashirelahi N; O'Toole JH; Young JD
    Biochem Med; 1976 Jun; 15(3):254-61. PubMed ID: 63282
    [No Abstract]   [Full Text] [Related]  

  • 35. Partial characterization and "quantitation" of a human prostatic estramustine-binding protein.
    Björk P; Forsgren B; Gustafsson JA; Pousette A; Högberg B
    Cancer Res; 1982 May; 42(5):1935-42. PubMed ID: 7066904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytosol oestrogen receptor of lactating mammary gland. Effect of heparin on the aggregation of the receptor and interaction of the receptor with heparin-Sepharose.
    Auricchio F; Rotondi A; Sampaolo P; Schiavone E
    Biochem J; 1978 Apr; 171(1):137-41. PubMed ID: 646813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dihydrotestosterone-binding characteristics in human prostatic adenoma].
    Gerasimova TsI; Smirnov AN; Buniatian AF
    Probl Endokrinol (Mosk); 1982; 28(5):37-42. PubMed ID: 6183657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and partial characterization of specific oestrogen-binding components in human kidney.
    Bojar H; Balzer K; Dreyfürst R; Staib W; Wittliff JL
    J Clin Chem Clin Biochem; 1976 Nov; 14(11):515-20. PubMed ID: 1003111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations of C-MYC, NKX3.1, and E-cadherin expression in canine prostate carcinogenesis.
    Fonseca-Alves CE; Rodrigues MM; de Moura VM; Rogatto SR; Laufer-Amorim R
    Microsc Res Tech; 2013 Dec; 76(12):1250-6. PubMed ID: 24030851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of androgen receptor in human prostatic tissues and demonstration of decreased androgen receptor content in metastatic prostate cancer.
    Kliman B; Prout GR; MacLaughlin RA
    Surg Forum; 1979; 30():550-1. PubMed ID: 94190
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.